237 related articles for article (PubMed ID: 22201709)
1. Protein targeting constructs in alpha therapy.
Olafsen T; Elgqvist J; Wu AM
Curr Radiopharm; 2011 Jul; 4(3):197-213. PubMed ID: 22201709
[TBL] [Abstract][Full Text] [Related]
2. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
3. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
[TBL] [Abstract][Full Text] [Related]
4. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
5. Radionuclide antibody-conjugates, a targeted therapy towards cancer.
Kitson SL; Cuccurullo V; Moody TS; Mansi L
Curr Radiopharm; 2013 Jun; 6(2):57-71. PubMed ID: 23808764
[TBL] [Abstract][Full Text] [Related]
6. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
7. Targeted Radioimmunotherapy and Theranostics with Alpha Emitters.
Pandit-Taskar N
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S41-S44. PubMed ID: 31451417
[TBL] [Abstract][Full Text] [Related]
8. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
Lindegren S; Frost SH
Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
[TBL] [Abstract][Full Text] [Related]
9. Development of Targeted Alpha Particle Therapy for Solid Tumors.
Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
[TBL] [Abstract][Full Text] [Related]
10. Current status and perspectives in alpha radioimmunotherapy.
Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
13. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
14. Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?
Allen BJ
Immunotherapy; 2011 Apr; 3(4):455-8. PubMed ID: 21463184
[No Abstract] [Full Text] [Related]
15. Astatine-211: production and availability.
Zalutsky MR; Pruszynski M
Curr Radiopharm; 2011 Jul; 4(3):177-85. PubMed ID: 22201707
[TBL] [Abstract][Full Text] [Related]
16. Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
Zalutsky MR; Schuster JM; Garg PK; Archer GE; Dewhirst MW; Bigner DD
Recent Results Cancer Res; 1996; 141():101-22. PubMed ID: 8722422
[No Abstract] [Full Text] [Related]
17. Radioimmunodetection and therapy of breast cancer.
DeNardo SJ
Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
[TBL] [Abstract][Full Text] [Related]
18. Experimental radioimmunotherapy.
Buchsbaum DJ
Semin Radiat Oncol; 2000 Apr; 10(2):156-67. PubMed ID: 10727604
[TBL] [Abstract][Full Text] [Related]
19. Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies.
Bethge WA; Sandmaier BM
Semin Oncol; 2004 Feb; 31(1):68-82. PubMed ID: 14970939
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
